SiNtx Technologies Inc (SINT)

[CL101]

This is my OPINION:

This is my take...Sonny's vision is to bring CSC + recently obtained worldwide patent to patients which totally eliminate the needs of painful 2nd site bone graft from patients. Hip, Knee, Shoulder, Dental will come along later as titanium, peek, even ceramtec COC (ceramic on ceramic) has no match for amda's si3n4, even the 1st gen already beats these biomaterial out there.

Current, traditional methods:

https://www.spine-health.com/treatment/spinal-fusion/autograft-patients-own-bone

CSC method will be a game changer forever! Less complicated procedures for surgeons & less risk of getting lawsuits. Cheaper for insurance company. Greatly reduce the pain for patients (no need to harvest bone from 2nd site) & faster healing time. Most important is reducing the needs to inject invasive anti-infective drugs post surgeries (esp. peek biomaterial = very high infection rate post surgery).

2 years blind studies of SNAP (CSC+si3n4 compares to traditional method):

https://link.springer.com/article/10.1007%2Fs00586-017-5079-6

Peek material controls 80+% of spine surgery market. Ceramtec COC (Ceramic on Ceramic = noisy, risk of fracture or crack = re-operation risk = painful) controls 90%+ of hip replacement market. As we all know, JNJ, Strykers, Zimmer, etc metal on metal hip replacement is tainted with $ billions of liabilities in lawsuits. It's all over the internet & even on TV. The recent PRs shows Zimmer colab with amda successfully tested their hip replacment using zimmer's liner & si3n4 fermol head:

www.mdpi.com/2075-4442/4/4/35/pdf

Biocompatible properties:

www.ijmse.net/uploadfile/2016/0715/20160715041827481.pdf

This lead me to think that Zimmer & amda are actually sleeping together. Will Zimmer marry Amda..Guess we will find out very soon.

Amda's is actually stepping on 2 giant's toes! Whoever is buying Amda is actually hitting a jackpot. I believe K2M was trying to merge with them, but Sonny possibly rejected it. Sonny knew by heart that only giant like Zimmer or bigger (JNJ, Strykers, etc) will have enough resources to help to bring the benefits of CSC + si3n4 to unfortunate patients.

In addition, the orders from China giant Weigao pending CFDA approval alone is somewhat $200+ mils already. Also, their NOLs is also $200+ mils. Also, we are not even including the Japan market pending the PMA approval too.

To be honest, I really don't know how much amda really worths.


Now you can go thru. this checklist:

https://www.forbes.com/sites/allbusiness/2014/12/19/20-key-due-diligence-activities-in-a-merger-and-acquisition-transaction/#57c8843d4bfc